Breast cancer screening: know your lifetime risk early

Breast cancer is rising, especially in younger women, and many of them are diagnosed late. In a conversation on the Dr. Hyman Show, a gynecologist and women's health advocate explains why standard screening misses so much and what to do about it. The guest was diagnosed with breast cancer despite a negative mammogram, a negative ultrasound and an MRI read as benign.

The access and dismissal problem

Half of US counties have no OB-GYN, so many women who find a lump cannot even see a specialist. When they do reach a medical office, the guest says, symptoms are often minimized or dismissed. The message: if a woman says something is wrong, almost always something is wrong.

Know your lifetime risk

Breast cancer affects one in eight women, a 12.5% chance. The guest compares that to boarding a plane with a 12.5% chance of crashing. And 85% of women with breast cancer have no family history. The guest had no family history, no genetic mutation, rarely drank, stayed thin and exercised a lot.

Instead of relying on age 40, the guest recommends calculating your lifetime risk with the Tyrer-Cuzick model. You enter age, height, weight, breast density, family history, age at first period, age at menopause and any abnormal biopsies. If the result is 20% or more:

• Start imaging as early as age 30.
• Get a mammogram, and add an ultrasound if you have dense breasts.
• Add an annual breast MRI when risk is above roughly 20% to 25%.

The guest's story

After a biopsy showed atypical lobular hyperplasia, the guest calculated a lifetime risk of 37%. The surgeon advised returning in six months. The guest instead pushed for a double mastectomy and was told they were anxious and paranoid. The surgery was difficult, and the pathology found an invasive stage one cancer in the opposite breast, not the one under observation. Looking back, the lesion was visible on the MRI that was read as benign.

Why dense breasts matter

Mammograms detect 75% to 85% of breast cancers, so 15% to 25% are missed. More than half of women over 40 have dense breast tissue, which appears white, as do cancers, so a small lesion gets lost in the background. The guest compares it to a muddy window. Advice:

1. If your report says dense breasts, ask for a 3D mammogram instead of a 2D.
2. Ask for a bilateral breast ultrasound.
3. Calculate your lifetime risk by 30, and ask for an MRI if it is 20% or more.

Genetics and polygenic risk

By 25, anyone with a family history of breast, ovarian, pancreatic or prostate cancer should ask about genetic cancer testing. About 11 single genes matter for breast cancer, including BRCA, PALB2, CHEK2 and ATM, and they can raise lifetime risk from 25% to as high as 80%. Yet fewer than 10% of women with breast cancer carry these mutations. Many more have a high polygenic risk score, meaning many small variants add up, and a result above the 90th percentile signals higher risk. No blood test tells you whether you will get breast cancer, but a multi-cancer test such as Galleri can add information.

What drives risk

The host highlights estrogen-related drivers: early puberty, later first births, fewer pregnancies, less breastfeeding, obesity from insulin resistance, lack of exercise and alcohol. Environmental xenoestrogens such as PCBs, phthalates, parabens and BPA add to the load, and a disrupted gut microbiome can recirculate estrogen. The same metabolic roots appear in PMS, fibroids, endometriosis and polycystic ovary syndrome, which the guest calls a metabolic disorder rather than an ovarian one.

Both experts recommend sleeping seven hours, exercising daily, lowering inflammation, reducing alcohol and toxins, and checking labs such as A1C, ApoB, lipoprotein(a), hs-CRP, homocysteine, vitamin D, B12 and ferritin. They also favor an annual pelvic ultrasound, which takes about a minute and involves no radiation.

Beyond breast cancer: PMOS and endometriosis

The guest says polyendocrine metabolic ovarian syndrome, the new name for PCOS, affects 10% to 13% of women and is mostly undiagnosed. Diagnosis needs two of three criteria: irregular periods, polycystic-looking ovaries or elevated AMH, and signs of high testosterone such as acne, facial hair or hair thinning. Driven by insulin resistance, it is often treated with birth control or antidepressants instead of food, exercise and a walk after each meal. The guest also notes that 61% of these patients have endometriosis, which can take nine to eleven years to diagnose.

Hormone therapy

The guest favors individualized care. Lifetime risk, genetics and metabolic health decide who is a candidate. For women at very high risk, options include tamoxifen, which cannot be combined with hormone replacement, or risk-reducing surgery followed by hormone therapy.

Conclusion

Do not wait for symptoms or age 40. Calculate your lifetime risk, know your breast density, ask about 3D imaging, and be your own advocate.